Sildenafil Citrate Tablet, Film Coated
Product Images NDC 82009-093

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 82009-093). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafil_fig1.jpg (Sildenafil Fig1)

Line graph showing the mean change from baseline in sitting systolic blood pressure over 24 hours for healthy volunteers comparing Sildenafil 100 mg and placebo. The x-axis represents time post dose in hours, and the y-axis represents systolic blood pressure changes in mmHg.*

FDA Label Image

Sildenafil_fig3 (Sildenafil Fig 3)

A line graph depicting mean standing systolic blood pressure change from baseline over time post-dose (0 to 8 hours). The graph compares two groups: Doxazosin plus placebo and Doxazosin plus Sildenafil 50 mg, showing changes in mmHg on the vertical axis and time in hours on the horizontal axis.*

FDA Label Image

Sildenafil_fig_4 (Sildenafil Fig 4)

A line graph showing mean standing systolic blood pressure change from baseline over time after dosing up to 8 hours. Two curves compare Doxazosin plus Sildenafil 100 mg and Doxazosin plus placebo, with blood pressure on the vertical axis and time after dosing (hours) on the horizontal axis.*

FDA Label Image

Sidenafil_fig_5 (Sildenafil Fig 5)

A line graph depicting mean plasma concentrations of Sildenafil over time in healthy male volunteers after administration of a commercial tablet. The x-axis represents time post dose in hours (0 to 24), and the y-axis shows plasma concentrations in ng/ml (0 to 500). The graph shows a peak concentration shortly after dosing followed by a gradual decline.*

FDA Label Image

100mg (Sildenafil 100mg)

Label for Sildenafil Tablets, USP 100 mg, film-coated tablets. The label indicates a package count of 100 tablets and includes a child-resistant packaging notice. It states the product is manufactured by Ajanta Pharma Limited and for Quallent Pharmaceuticals Health LLC. The label shows a space for lot and expiration dates and includes a barcode.*

FDA Label Image

Sildenafil-fig7 (Sildenafil Fig7)

A vertical bar chart showing the percentage of patients reporting improvement across four treatment groups: Placebo, Sildenafil Tablets 25 mg, Sildenafil Tablets 50 mg, and Sildenafil Tablets 100 mg. The percentages increase progressively from placebo at 24% to the highest at 82% for Sildenafil Tablets 100 mg.*

FDA Label Image

Logo (Sildenafil Logo)

FDA Label Image

Str (Sildenafil Structure)

Chemical structure diagram of Sildenafil, the active ingredient in Sildenafil Citrate 100 mg oral tablets by Quallent Pharmaceuticals Health LLC. The diagram shows the molecular arrangement of atoms and bonds typical for this compound.*

FDA Label Image

Figure2 (Sildenafil Fig2)

A line graph showing change in EBP (mmHg) over time postdose in hours for two treatments: Doxazosin with placebo (blue line) and Doxazosin with Sildenafil 25 mg (black line). The graph tracks blood pressure changes up to 8 hours following dosing.*

FDA Label Image

Sildenafil_fig6b (Sildenafil Fig6b)

A bar chart showing the percentage of patients at endpoint for different baseline scores ranging from 0 to 5. Each score category displays multiple bars representing varying data series, with a legend indicating different groups or treatments. The y-axis represents the percentage of patients, and the x-axis represents the baseline scores.*

FDA Label Image

Sildenafil_fig6a (Sildenafil Figure6a)

A bar chart depicting the percentage of patients at endpoint across different baseline scores for Sildenafil Citrate. The x-axis represents the baseline score ranging from 0 to 5, while the y-axis shows the percentage of patients. Multiple bars for each baseline score reflect different response categories, with a visible legend indicating score values from 0 to 5.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.